Tizanidine 76420-0865-30
- Manufacturer
- Asclemed Usa, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- June 15, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA076286
Need to source Tizanidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tizanidine Hydrochloride | 2 mg/1 |
Drug Class
Adrenergic alpha2-Agonists [MoA]Central alpha-2 Adrenergic Agonist [EPC]
Selected Package
76420-0865-30Selected30 TABLET in 1 BOTTLE (76420-865-30)
Other packages for this product(4)
120 TABLET in 1 BOTTLE (76420-865-12)
150 TABLET in 1 BOTTLE (76420-865-15)
60 TABLET in 1 BOTTLE (76420-865-60)
90 TABLET in 1 BOTTLE (76420-865-90)